Menu

Home / For Visitors / 2024 Exhibitor List / APEXCELLA BIOMEDICAL INC.

APEXCELLA BIOMEDICAL INC.

Area: Government, Academia and Research Institutes

Booth No: N406

Website: https://www.apexcella.com/

Exhibitor Profile

Apexcella Biomedical has developed unique ApexNK® expansion technology that enables the mass production of NK cells with high purity and high cytotoxicity to provide affordable allogeneic NK or CAR-NK cell therapies to respond to unmet medical needs. Apexcella will initiate the Phase I trials of allogeneic ApexNK® cells with therapeutic antibodies to treat lymphoma or solid tumors in 2025. The first CAR-ApexNK candidate is expected to file IND in 2026. We also welcome strategic partners who are willing to use ApexNK® platform to develop CAR-NK therapies with novel targets.

Exhibitors you may be interested in

Highest Rated

TOP